Acute alcohol withdrawal, National Institute for Health and Care Excellence, 2015, http://pathways.nice.org.uk/pathways/alcohol-use-disorders.
Fang J, McKay G, Song J, Remillrd A, Li X, Midha K. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome P450 enzymes and human liver microsomes. Drug Metab Dispos 2001;29:1638–43.Google Scholar
Ghosh C, Marchi N, Desai NK, Puvenna V, Hossain M. Cellular localization and functional significance of CYP3A4 in the human epileptic brain. Epilepsia 2011;52:562–71.Web of SciencePubMedCrossrefGoogle Scholar
Langaee T, Hamadeh I, Chapman AB, Gums JG, Johnson JA. A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication. PLoS One 2015;10:e0113808.CrossrefWeb of SciencePubMedGoogle Scholar
Crews KR, Gaedigk A, Dunnenberger HM, Klein TE, Shen DD. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin Pharmacol Ther 2012;91:321–6.CrossrefWeb of SciencePubMedGoogle Scholar
Nakamura A, Mihara K, Nemoto K. Lack of correlation between the steady-state plasma concentrations of aripiprazole and haloperidol in Japanese patients with schizophrenia. Ther Drug Monit 2014;36:815–8.PubMedWeb of ScienceCrossrefGoogle Scholar
Gasso P, Papagianni K, Mas S. Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers. Pharmacogenomics 2013;14:1551–63.CrossrefPubMedWeb of ScienceGoogle Scholar
Sychev DA, Zastrozhin MS, Smirnov VV, Savchenko LM, Bryun EA, Guschina YuSh, et al. Association of isoenzyme CYP2D6 activity with efficacy and safety profile of haloperidol in patients with compulsive affection for alcohol. Bulletin of RSMU 2015;4:36–39.Google Scholar
Sychev DA, Zastrozhin MS, Smirnov VV, Grishina EA, Savchenko LM, Bryun EA. The correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction. Pharmacogenomics Pers Med 2016;9:1–7.Web of ScienceGoogle Scholar
Pan L, Belpaire FM. In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol. Eur J Clin Pharmacol 1999;55:599–604.CrossrefGoogle Scholar
Drago A, Giegling I, Schäfer M, Hartmann AM, Möller HJ, De Ronchi D, et al. No association of a set of candidate genes on haloperidol side effects. PLoS One 2012;7:e44853.CrossrefPubMedWeb of ScienceGoogle Scholar
Van der Weide K, van der Weide J. The influence of the CYP3A4*22 polymorphism and CYP2D6 polymorphisms on serum concentrations of aripiprazole, haloperidol, pimozide, and risperidone in psychiatric patients. J Clin Psychopharmacol 2015;35:228–36.CrossrefWeb of SciencePubMedGoogle Scholar
Zastrozhin MS, Smirnov VV, Sychev DA, Savchenko LM, Bryun EA, Guschina Y, et al. Study of carbamazepine influence on activity of cytochrome P-450 3A4 isoenzyme in patients with alcohol use disorder. Exp Clin Pharmacol 2016;10:18–22.Google Scholar
Tay-Sontheimer J, Shireman LM, Beyer RP. Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomics. Pharmacogenomics 2014;15: 1947–62.PubMedWeb of ScienceCrossrefGoogle Scholar
Luo X, Li X, Hu Z, Cheng Z. Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism. Acta Pharmacologica Sinica 2009;30:1323–9.CrossrefPubMedWeb of ScienceGoogle Scholar
About the article
Published Online: 2017-08-08
Published in Print: 2017-09-26
Author contributions: DAS, MSZ1, IIM, LMS, and EAB analyzed the data. DAS, MSZ1, LMS, and EAB conceived and designed the study and supervised the work. DAS, MSZ1, IIM, NVB, EAG, LMS, and EAB wrote the reply to the reviewers and the revised manuscript. MSZ2 recruited the patients. EAG, KAR, KBM, DDM, NES, and ASS performed the genotyping of CYP2D6 and CYP3A5. VVS performed the phenotyping of CYP2D6 and CYP3A. IIM and NVB performed TDM. VS and PN performed translation. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved its submission.
Research funding: This work was supported by the Russian Science Foundation under the project 16-15-00227 “Fundamental research and exploratory research in priority areas of research.”
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.